BiotechTube
Home/Hera Biotech/Kelly Mottet, MSc, BSc
KM

Kelly Mottet, MSc, BSc

Head of Quality Management & Regulatory Affairs

Hera Biotech

Therapeutic Areas

EndometriosisCervical Cancer

Hera Biotech Pipeline

DrugIndicationPhase
MetriDx™Endometriosis detection and stagingPre-clinical
HERAfem™Cervical cancer (CIN1+) detectionPre-clinical

Leadership Team at Hera Biotech

SB
Somer Baburek, MBA
President, CEO & Board Member
CD
Cinzia Donato, PhD
COO & CSO
JS
Jesus Seañez, PhD, BS
Head of Product & Technology
View full Hera Biotech profile